
Jeff Krasno discusses the implications of the gray-market collapse of peptide vendors and explores the science behind various peptides.
In March 2026, the largest gray-market peptide vendor in the U.S. went dark overnight. No refunds, and a wave of uncertainty about what these products actually are, how they’re sourced, and whether they’re worth the risk.In this episode, Jeff works through what peptides actually are, where the science holds up and where it doesn't, and what the gray-market collapse means for anyone paying attention to this space. Topics covered: BPC-157, CJC-1295, ipamorelin, and TB-500: what the research actually shows Why are oral peptide capsules mostly expensive amino acids The sourcing landscape: FDA-approved, compounding pharmacies, and gray market Who peptide therapy may be right for, and who should wait Free, evidence-backed alternatives for GH optimization and injury recovery This episode is for anyone who's been curious about peptide injections and wants the honest answer, not the Joe Rogan version. This episode was made possible by: Sunlighten: Visit sunlighten.com/commune Up to 2,100 off saunas and $50 off Red Light Products with code “COMMUNE” Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE Stemregen: Get 20% off your first order at…
Host: Jeff Krasno
Sunlighten, Bon Charge, Stemregen, Vivobarefoot, Beyond Biohacking
Products: BPC-157, CJC-1295, ipamorelin, TB-500
Explore listener stats, chart rankings, contacts and more on the Commune with Jeff Krasno podcast page.